Health Status after Transcatheter Mitral Valve Repair in Patients with Heart Failure and Secondary Mitral Regurgitation: COAPT Trial

BACKGROUND: In the COAPT trial, transcatheter mitral valve repair (TMVr) with the edge-to-edge device led to reduced heart failure (HF) hospitalizations and improved survival in patients with symptomatic HF and 3-4+ secondary mitral regurgitation (MR) on maximally-tolerated medical therapy. Given th...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Am Coll Cardiol
Glavni autori: Arnold, Suzanne V., Chinnakondepalli, Khaja M., Spertus, John A., Magnuson, Elizabeth A., Baron, Suzanne J., Kar, Saibal, Lim, D. Scott, Mishell, Jacob M., Abraham, William T., Lindenfeld, JoAnn A., Mack, Michael J., Stone, Gregg W., Cohen, David J.
Format: Artigo
Jezik:Inglês
Izdano: 2019
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6499691/
https://ncbi.nlm.nih.gov/pubmed/30894288
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jacc.2019.02.010
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items